Reported Reactions

Devices › Device types

FDA product code JCT · class 2 · General, Plastic Surgery

Prosthesis, tracheal, expandable: medical device reports filed with FDA

3,011 reports carry this product code, 1996–2026; 12 brands with a page.

3,011
reports with this product code
0% of all MAUDE reports
72
reports, 12 months to August 2026
54 in the 12 months before
52.9%
classified as malfunction
62.3% across all reports
3.6%
classified as death, as reported
0.9% across all reports

Product code JCT is FDA's classification for "Prosthesis, tracheal, expandable" (general, Plastic Surgery panel), a class 2 device. 3,011 medical device reports carry this product code, 0% of the MAUDE database, from October 1996 to August 2026.

72 reports arrived in the 12 months to August 2026, up 33% from 54 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (52.9%), injury (42.3%) and death (3.6%). 12 brand names with a page on this site carry this code; the brands table is ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Brands with this product code

BrandReportsLatest 12 monthsClassified as deathClassified as malfunction
Ultraflex Tracheobronchial690510.3%59.5%
Fluency Plus Tracheobronchial Stent Graft31200%90.7%
Icast Covered Stent24409.8%42.9%
Atrium Icast Covered Stent20700.5%2.4%
WALLSTENT Endoprosthesis48141.4%57.7%
GORE VIABAHN Endoprosthesis36185.8%23.5%
Ultraflex2304.5%38.9%
Wallstent Enteral Endoprosthesis14010.5%23.5%
Wallstent Biliary850.6%72.7%
Advanta V12 Covered Stent3012.6%37.9%
Wallstent Endoprosthesis With Unistep Plus Delivery System102.9%36.9%
Wallstent Rx Biliary Endoprosthesis100.5%36.9%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Manufacturers named

Manufacturer (as written on reports)ReportsShare
Atrium Medical80826.8%
Boston Scientific - Galway63121%
Boston Scientific Ireland1224.1%
Angiomed & Medizintechnik Kg1153.8%
W L Gore & Associates501.7%
Bard Peripheral Vascular250.8%
Merit Medical Systems180.6%
Ev3100.3%
Bard10%

Reports by month, five years

01835Sep 2021: 9Oct 2021: 10Nov 2021: 2Dec 2021: 52022Jan 2022: 7Feb 2022: 3Mar 2022: 3Apr 2022: 3May 2022: 0Jun 2022: 4Jul 2022: 8Aug 2022: 15Sep 2022: 3Oct 2022: 3Nov 2022: 5Dec 2022: 72023Jan 2023: 6Feb 2023: 7Mar 2023: 14Apr 2023: 7May 2023: 7Jun 2023: 7Jul 2023: 9Aug 2023: 6Sep 2023: 15Oct 2023: 9Nov 2023: 5Dec 2023: 182024Jan 2024: 6Feb 2024: 11Mar 2024: 9Apr 2024: 7May 2024: 5Jun 2024: 5Jul 2024: 9Aug 2024: 5Sep 2024: 8Oct 2024: 4Nov 2024: 3Dec 2024: 42025Jan 2025: 9Feb 2025: 3Mar 2025: 6Apr 2025: 4May 2025: 2Jun 2025: 3Jul 2025: 5Aug 2025: 3Sep 2025: 4Oct 2025: 6Nov 2025: 2Dec 2025: 32026Jan 2026: 3Feb 2026: 1Mar 2026: 2Apr 2026: 5May 2026: 6Jun 2026: 3Jul 2026: 35Aug 2026: 2

FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

Event type and report source

Event type

Death3.6%108
Injury42.3%1,273
Malfunction52.9%1,594
Other0.8%23
Not given0.4%13

Who filed

Manufacturer report95.7%2,881
Voluntary report1.7%52
User facility report0%0
Distributor report0%0
Not given2.6%78

Grey bar: all 26,136,888 MAUDE reports.

Device problems coded

Device problem (FDA code)ReportsShare
Activation, positioning or separation problem42013.9%
Positioning failure40413.4%
Breakthe device broke2347.8%
Fracturea broken bone1785.9%
Positioning problem1665.5%
Detachment of device component1595.3%
Difficult to removethe device was hard to remove1394.6%
Replace1384.6%
Material deformation1234.1%
Activation failure1214%
Migration or expulsion of device1143.8%
Difficult or delayed positioning1103.7%
Device dislodged or dislocated973.2%
Device remains implanted712.4%
Explanted662.2%
Material separation662.2%
Sticking642.1%
Failure to advance632.1%
Device, removal of (non-implant)602%
Occlusion within devicethe device blocked561.9%

Questions about prosthesis, tracheal, expandable reports

What is product code JCT?

FDA's classification code for "Prosthesis, tracheal, expandable", class 2, reviewed by the general, Plastic Surgery panel. Every device report carries the product code of the device involved.

How many reports carry this code?

3,011 reports through August 2026, 72 of them in the latest 12 months.

Which brands appear most often?

Ultraflex Tracheobronchial (690), Fluency Plus Tracheobronchial Stent Graft (312), Icast Covered Stent (244), Atrium Icast Covered Stent (207) and WALLSTENT Endoprosthesis (48). Widely used products collect more reports because more people use them.

Can the brands table be used to rank the devices?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." Brands differ in how many are in use, how long they have been sold and how reports are collected.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.